Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	31.44B
Revenue (ttm)	9.42B
Net Income (ttm)	1.15B
Shares Out	1.48B
EPS (ttm)	0.79
PE Ratio	26.91
Forward PE	22.14
Dividend	0.25 (1.20%)
Ex-Dividend Date	Jul 10, 2025

Volume	38,608,203
Average Volume	42,054,101
Open	20.65
Previous Close	20.82
Day's Range	20.50 - 21.45
52-Week Range	13.49 - 24.24
Beta	0.36
RSI	49.93
Earnings Date	Aug 26, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.